Frontlight ResearchEarly access
Active, not recruitingNo phase
The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection(BROAD)
Key facts
- Who runs it
- Permed Biomedical Engineering Co., Ltd
- Where
- China18 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 259 people, planned
- Started
- 18 Jan 2023
- Expected to end
- 28 Feb 2029
- Type of study
- Interventional, 3 groups
- Treatments tested
- PerMed Stent Graft System In Surgical Operation
- Endovastec CRONUS® Intraoperative stent system
- Record updated
- 3 June 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- Age ≥ 18 and ≤ 75 years, male or female
- Stanford type A aortic dissection subjects with involvement of the descending arch aorta;
- Subjects treated with stent pictorial procedures as judged appropriate by the investigator;
- Subjects or their legal surrogates were able to understand the purpose of the study, had adequate compliance to the clinical study protocol, and voluntarily signed the informed consent form
Who cannot take part
- Subjects who had undergone open surgical procedures of the cardiocerebral vasculature within 90 days prior to surgery
- Subjects with aortic dissection with severe malperfusion syndrome preoperatively (e.g., subjects presenting with coma, paraplegia, need for dialysis, gastrointestinal necrosis or limb necrosis due to ischemia, etc.)
- Subjects with acute systemic infection, severe infection and associated sepsis, shock or multiple organ failure
- Subjects with history of active bleeding, coagulopathy or refusal of blood transfusion
- Subjects known to be allergic to materials such as contrast agents, nitinol alloys, coated artificial blood vessels
- Subjects with a life expectancy of less than 12 months (other than disease due to aortic dissection)
- Subjects with poor compliance other conditions that the investigator considers inappropriate for participation in the clinical trial
- Subjects with aortic dissections confined to the ascending and / or arch
- Subjects with a left common carotid artery branch vessel diameter < 5 mm or > 16 mm (not applicable to subjects enrolled with a single branch structure)
- Subjects with a left subclavian artery branch vessel diameter < 7 mm or > 16 mm
- Subjects with vertebral artery variants
- Subjects with infectious aortic dissections
- Subjects unable to tolerate anaesthesia and cardiopulmonary bypass
- Subjects being enrolled in other clinical trials
- Pregnant and lactating women, and subjects with a recent pregnancy preparation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the study was to evaluate the safety and efficacy of a branched type intraoperative stent system for the treatment of Stanford type A aortic dissection
The 3 groups in the trial
- Branched Surgical Stent Graft System,Treatment being tested
Learning curve case group Experimental: Beijing PerMed Branched Surgical Stent Graft System,Permedos apex.
Treatment: PerMed Stent Graft System In Surgical Operation
- Single Branch Structure Stent Graft System single groupTreatment being tested
Beijing PerMed single branch intraoperative stent system
Treatment: PerMed Stent Graft System In Surgical Operation
- CRONUS® Stent Graft System In Surgical OperationOther group
Control group:CRONUS® Stent Graft
Treatment: Endovastec CRONUS® Intraoperative stent system
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multicenter, Open, Randomized Controlled, Non Inferiority Clinical Trial to Evaluate the Safety and Efficacy the Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection
- Record updated
- 3 June 2025